ARTICLE
Curve-Flattening Immobility May Set Cross-Border Tax Traps
March 30, 2020
Read time: 1 min
ARTICLE
March 30, 2020
Read time: 1 min
ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 5 min
The protective governmental measures to prevent the spread of the COVID-19 pandemic, in particular, the restrictions on the assembly of persons, affects the ability of companies to act. For the time being, Stock Corporation (Aktiengesellschaften) cannot hold general meetings in the physical presence of their shareholders. However, the presence meeting is required by law for the stock corporation, in particular for the annual general meeting (AGM) to pass a resolution on the appropriation of the balance sheet profit.
The legislator has taken action and with the bill to mitigate the consequences of the COVID-19 pandemic, inter alia, in company law, companies now have various options to act in spite of the restrictions on the right of assembly.
The law is due to come into force in March and will apply retroactively from March 1 2020. It provides the following simplifications, limited to the calendar year 2020, for resolutions to be passed at AGMs:
This year, the management board of a stock corporation can enable online participation in the AGM without the authorization of the articles of association of the respective company. The AGM can then take place virtually without any physical presence of the shareholders if;
All mentioned measures need the approval of the supervisory board, who is entitled to take the decisions without physical presence of its members, but in writing, by telephone or in a comparable manner regardless of the regulations in statutes or rules of procedure.
The option for appealing against resolutions of the AGM, in particular due to deficiencies in the electronic communication options or the implementation of the virtual AGM itself, are limited as far as possible.
Even without any authorization under the statutes, the Board of Directors may resolve to pay an advance on the net retained profits (interim dividend – Zwischendividende), subject to the other legal requirements.

ARTICLE
March 30, 2020
Read time: 7 min
Since the 20 March 2020 announcement of the temporary Coronavirus Job Retention Scheme, which is intended to support UK employers whose operations have been severely affected by Coronavirus (COVID-19), the UK government has published further details and guidance. On 27 March 2020, the Government also announced that it will amend the Working Time Regulations in order to allow statutory annual leave to be carried over into the next two years. This article offers a review of key aspects of this guidance to help employers address the ongoing challenges posed by COVID-19.
The UK government has now published further details of the temporary Coronavirus Job Retention Scheme which it announced on 20 March 2020.
The scheme is intended to support UK employers whose operations have been severely affected by Coronavirus (COVID-19) by allowing those employers to furlough employees for whom there is currently no work.
Employers can use a portal to claim for 80% of furloughed employees’ (employees on a leave of absence) usual monthly wage costs, up to £2,500 a month, plus the associated Employer National Insurance contributions and minimum automatic enrolment employer pension contributions on that wage.
This alert provides a summary of some key aspects of the guidance on the temporary Coronavirus Job Retention Scheme. The full guidance can be accessed here.
WHO CAN USE IT
Any UK organisation with employees, including:
This is subject to having a PAYE payroll scheme in place on or before 28 February 2020 and having a UK bank account.
WHAT EMPLOYEES ARE COVERED
An employee who was on the PAYE payroll on 28 February 2020 and on any type of contract, including: full-time employees; part-time employees; employees on agency contracts; employees on flexible or zero-hour contracts.
An employee working on reduced hours, or for reduced pay, is not covered.
The scheme also covers employees who were made redundant since 28 February 2020, if they are rehired by their employer.
Employees hired after 28 February 2020 cannot be furloughed.
WHAT’S COVERED
80% of furloughed employees’ (employees on a leave of absence) usual monthly wage costs, up to £2,500 a month, plus the associated Employer National Insurance contributions and minimum automatic enrolment employer pension contributions on that wage.
Fees, commissions and bonuses are not included.
HOW IS IT CALCULATED
For full time and part time salaried employees, the employee’s actual salary before tax, as of 28 February 2020 should be used to calculate the 80%. Fees, commission and bonuses should not be included.
If an employee’s pay varies and they have been employed for a full twelve months prior to the claim, it is the higher of: the same month’s earnings from the previous year; or average monthly earnings from the 2019-2020 tax year.
If the employee has been employed for less than a year, you can claim for an average of their monthly earnings since they started work.
Once you’ve worked out how much of an employee’s salary you can claim for, you must then work out the amount of Employer National Insurance Contributions and minimum automatic enrolment employer pension contributions you are entitled to claim.
WHAT ABOUT INCOME TAX
The wage you pay to furloughed employees will be subject to tax and other National Insurance contributions. You are also still liable for the minimum automatic enrolment employer pension contributions.
WHAT ABOUT TOP UP?
You can choose to provide top-up salary in addition to the grant but, to be eligible for the scheme, you do not have to. However, if you do not propose to do so, you should make this clear to employees with a view to obtaining their consent (whether express or implied).
Employer National Insurance Contributions and automatic enrolment contributions on any additional top-up salary will not be covered by the Government scheme. Nor will any voluntary automatic enrolment contributions above the minimum mandatory employer contribution of 3%.
WHAT ABOUT NLW/NMW?
As employees are not working, it does not matter if the 80% takes them below the NLW/NMW.
However, if furloughed employees are required to, for example, complete online training courses whilst they are furloughed, then they must be paid at least the NLW/NMW for the time spent training, even if this is more than the 80% reimbursed by the Government.
WHAT CAN THE EMPLOYEE DO DURING FURLOUGH?
Nothing for the employer. This includes providing any services or generating any revenue.
However, they are able to undertake training and do volunteer work, provided they do not provide services to or make any money for their employer.
WHAT IS THE PROCESS FOR CHOOSING WHICH EMPLOYEES TO FURLOUGH?
There are no set rules. There is no requirement in the guidance for a formal selection exercise. However, equality and discrimination laws will apply in the usual way (as will the implied term of trust and confidence).
CAN FURLOUGH BE ROTATED BETWEEN EMPLOYEES?
Furlough leave must be taken in minimum blocks of three weeks to be eligible for funding. There is nothing in the guidance which prohibits rotating furlough leave amongst employees, provided each employee is off for a period of at least three weeks.
WHAT ABOUT OTHER FORMS OF LEAVE?
Employees on sick pay or self-isolating cannot be furloughed, but can be furloughed afterwards. Employees who are shielding can be placed on furlough.
Employees on maternity (or similar) leave can continue to draw SMP (or similar) payments. The guidance does not prohibit women on maternity leave agreeing to return to work early and then being furloughed, or electing to change to shared parental leave and then being furloughed, save that mothers must take the mandatory two weeks’ leave immediately following the birth of the baby.
Employees on unpaid leave cannot be furloughed, unless they were placed on unpaid leave after 28 February 2020.
Employers can only claim once every three weeks, i.e., they cannot get weekly reimbursement. Claims can be backdated to 1 March 2020.
WHAT DO YOU NEED TO MAKE A CLAIM
To make a claim, employers will need:
WHAT IS THE PROCESS AFTER YOU HAVE CLAIMED?
Once HMRC have received the employer’s claim and you are eligible for the grant, they will pay it via BACS payment to the employer’s UK bank account.
Employers must pay the employee the full grant received for their gross pay and are unable to charge fees on the money that is granted.
On 27 March 2020, the Government also announced that it will amend the Working Time Regulations in order to allow statutory annual leave to be carried over into the next two years. Key points of note include:

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 6 min
The COVID-19 pandemic has severely disrupted the daily lives of individuals and businesses across the United States as the federal and local governments continue to enact restrictions and preventative measures to stem the tide of infection.
This Alert focuses on some of the logistical issues of notarizing documents in person while abiding by restrictions to work remotely and maintain social distancing through the utilization of Remote Online Notarizations in New York State.
Pursuant to Governor Cuomo’s Executive Order No. 202.7, New York State notaries are permitted to notarize documents using audio-visual technology through April 18, 2020. This temporary transition to remote notarization is intended to facilitate legal transactions while maintaining the social-distancing measures enacted in New York and across the county in response to the COVID-19 crisis.
Remote notarization allows a signer who would traditionally appear in person before a notary to meet with the notary virtually using audio-visual technology. States that have authorized remote notarization require the notary to verify the signer’s identity through authentication methods such as a credential check or the use of third-party identity verification systems. In addition, notaries must keep both a journal and an audio-visual recording of the notarization. Typically, a signer can be situated in any state as long as the notary is present in the state in which he or she is commissioned.
Pursuant to the New York State Executive Order, parties using remote notarization must meet conditions which vary slightly from those required by other states. The signer must present valid photo identification to the notary during the videoconference, and both the signer and notary must be present in New York State. The notary does not need to make an audio-visual recording of the session. The complete list of conditions is below:
State authorization of remote notarization is a growing trend throughout the United States. Twenty three states have passed authorizing legislation, although many of these laws are pending full implementation. In addition, measures allowing for the temporary use of remote notarization during the COVID-19 crisis have been enacted outside of New York, in Connecticut, New Hampshire and Vermont (Vermont allows remote notarization for paper documents only). More narrowly, Pennsylvania is temporarily allowing the use of remote notarization for all commercial real estate transactions and for personal real estate transactions that were in process at the time of Pennsylvania’s COVID-19 disaster declaration. Finally, Iowa, Washington and Wisconsin, which each have remote notarization legislation becoming effective later this year, have authorized the interim use of remote notarization.
Remote notarization will make executing deals during the COVID-19 crisis simpler and safer for signers and notaries. However, questions have arisen regarding the acceptance for recordation of these documents by out-out-state recorder’s offices. For example, will a document remotely notarized in New York be accepted for recording in a state which does not allow remote notarization, such as California?
Currently, there is no uniform legislation governing a state’s acceptance of remotely notarized documents. Generally, a state will accept documents notarized in a second state for recording if the document accords the laws of the second state, and a state which allows remote notarization will accept documents remotely notarized in other states. However, each state ultimately sets its own rules about which remotely notarized out-of-state documents it will accept for recording.
A bipartisan bill titled the Securing and Enabling Commerce Using Remote and Electronic Notarization Act of 2020 (“SECURE Notarization Act”), introduced in Congress on March 18, 2020, would set minimum standards for remote notarization in each state and would require states to accept remotely notarized out-of-state documents which affect interstate commerce. However, the bill has run into some resistance from states, including California, concerned that the bill impinges upon states’ rights.
Until any such widespread acceptance of remote notarization, out-of-state remotely notarized documents will likely be accepted for recording in the states which already permit the use of remote notarization, but parties seeking to record such documents should consult with the relevant recorder’s office about the office’s requirements. As some county recorders’ offices may be subject to closures or limited operating hours during the COVID-19 outbreak, the ALTA Recording Jurisdictions – Operating Status tool may serve as a reference regarding the best methods of contact.
Authored by Julian M. Wise.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or the author.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 2 min
The federal and New York State governments have passed a series of new laws to respond to the emergent problems caused by COVID-19. The most ambitious of the new federal laws is the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), signed into law on March 27, 2020. Numerous provisions of the CARES Act and other laws enacted in recent weeks provide for financial benefits to individuals. This SRZ Alert summarizes the impact of the new federal and New York State laws on individuals.
Read full Alert .
Authored by Mark E. Brossman, Ian L. Levin and Ronald E. Richman.
The Alert authors would like to acknowledge the thoughtful input from many SRZ colleagues, including Julian M. Wise, Scott A. Gold, Amiel Y. Mandel, Melissa J. Sandak, Abdulrahman Alwattar and Adam B. Gartner.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 5 min
Among the many aspects of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) passed by Congress last week and signed into law, are those that cover tax-qualified retirement plans, including 401(k) plans and defined benefit pension plans. Specifically, the stimulus legislation provides greater flexibility to participants in defined contribution plans who are impacted by the pandemic to access more of their account balances. It also allows plan sponsors of all tax-qualified retirement plans, including single, multiple and multiemployer defined benefit pension plans, to amend their plans to permit participants who experience certain financial hardships as a result of the COVID-19 pandemic to receive early distributions without an early distribution penalty.
Qualified Individuals
Under the CARES Act, “Qualified Individuals” are eligible to take special distributions and increased loans from defined contribution plans. In general, a person is a “Qualified Individual” if:
A plan administrator may rely on an employee’s certification that the conditions for the employee to receive a special distribution have been met.
Distribution Amounts and Tax Treatment
Until Dec. 31, 2020, plan sponsors of tax-qualified retirement plans, including IRAs, defined benefit and defined contribution plans, may amend their plans to permit Qualified Individuals to take distributions of up to $100,000. For federal tax purposes, the amount of a Qualified Individual’s distribution may be spread (to the extent taxable) equally over three years, and if made to anyone under the age of 59-1/2, a distribution will not be subject to a 10% early distribution tax. Importantly, participants should be aware that the tax treatment of these distributions may differ under state tax laws. While a distribution to a Qualified Individual is not a loan, it may be repaid, at any time during the three-year period following the withdrawal, to any eligible plan that the individual becomes a participant to or an IRA.
Increased Loan Limits
Plan sponsors of defined contribution plans can amend their plans to enable participants who are Qualified Individuals to take enhanced loans of up to the lesser of 100% of the participant’s vested account balance or $100,000 (ordinarily, 50% of the participant’s vested account balance or $50,000). These enhanced loans are available only for the next 180 days. Plans may also be amended to allow participants who have existing outstanding loans for the rest of the calendar year to delay repayment of such loans for one year.
Plan Amendments
The availability of distributions to Qualified Individuals and increased loan limits can be implemented immediately. Timely plan amendments that reflect any implemented measures can be adopted later.
The CARES Act provides relief to individuals who would otherwise be required to withdraw required minimum distributions (often referred to as “RMDs”) in 2020 from defined contribution plans, including 401(k) plans, 403(b) plans and certain 457(b) plan (as well as IRAs). RMDs that would otherwise have been required to be made from those plans to an individual whose required beginning date occurs in 2020 may be delayed until 2021. The delay does not apply to any RMD that should have been made before Jan. 1, 2020 and RMDs under defined benefit pension plans.
Minimum Required Contributions by Employers
The CARES Act allows employers to delay until Jan. 1, 2021 minimum contributions to single employer defined benefit pension plans (including multiple employer plans) that an employer would otherwise be required to make (including quarterly contributions) during the 2020 calendar year (regardless of the applicable plan year). Each delayed contribution will be subject to interest from the original due date through the date the amounts are contributed to the pension plan.
Benefit Restrictions
The CARES Act provides relief from certain benefit restrictions that would otherwise have been triggered by a pension plan’s lower funding status (its “adjusted funding target attainment percentage” or “AFTAP”). If a pension plan does meet statutorily established funding thresholds, certain restrictions may be imposed on the plan, such as restricting lump sum distributions. To avoid such restrictions from being imposed on pension plans whose funding levels decline due to the COVID-19 pandemic, the CARES Act permits a plan sponsor to elect to treat the plan’s adjusted funding target attainment percentage for the last plan year ending before Jan. 1, 2020, as the AFTAP for plan years which include the 2020 calendar year.
Authored by Mark E. Brossman, David M. Cohen, Ian. L. Levin, Ronald E. Richman, Susan E. Bernstein and Melissa J. Sandak.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 3 min
On March 25, 2020, the Senate unanimously passed the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). On March 27, 2020, the CARES Act passed the House of Representatives and President Trump signed the bill into law.
The CARES Act is an emergency stimulus package that provides $2 trillion in aid to provide financial support to individuals and businesses that have been affected by the coronavirus pandemic. In particular, Title IV of the CARES Act, referred to as the “Coronavirus Economic Stabilization Act of 2020” (“CESA”), provides that from now until Dec. 31, 2020, the Secretary of the Treasury (“Secretary”) is authorized to make loans, guarantees and “other investments” to support certain eligible businesses, as well as state and local governments, of up to $500 billion in the aggregate. Of the $500 billion allocated for the relief program under CESA, (i) up to $25 billion is available for loans and guarantees for passenger air carriers; (ii) up to $4 billion is available for loans and guarantees for air cargo carriers; (iii) up to $17 billion is available for loans and guarantees for businesses critical to maintaining national security; and (iv) up to $454 billion (plus any amounts not actually given out under (i) through (iii)) is available for loans, guarantees, or other investments to support programs established by the Board of Governors of the Federal Reserve System (“Federal Reserve”) “for the purpose of providing liquidity to the financial system that supports lending to eligible businesses, States, or municipalities.”[1]
The CARES Act and other recent legislation also effectuates certain tax law changes and payroll and social security tax relief that are also addressed in this Alert.
Authored by Stuart D. Freedman, Andrew J. Fadale, Ian L. Levin, David J. Passey, Joseph P. Vitale, Kristen Q. Lin and Jessica Romano.
The Alert authors would like to acknowledge the thoughtful input from many SRZ colleagues, including Mark E. Brossman, Ronald E. Richman, Alan S. Waldenberg, Scott A. Gold, Melissa J. Sandak, Abbey Walsh, Abdulrahman Alwattar, Evan A. Berger, Cristell M.S. Fortune, Adam B. Gartner and Joseph Reich.
[1] On March 23, 2020, the Federal Reserve announced that it expects to establish a Main Street Business Lending Program. CESA clarifies that the loan and guaranty program for mid-size businesses would be in addition to the Main Street Business Lending Program established by the Federal Reserve.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 4 min
On March 25, 2020, the Securities and Exchange Commission issued an order[1] (“Updated Order”), under the “public interest” powers in Section 206A of the Investment Advisers Act of 1940, expanding the coverage of the temporary relief extending the upcoming Form ADV and Form PF filing deadlines that was provided in an earlier March 13, 2020 order[2] (“Original Order”).
This relief originally was limited to Form ADV and Form PF filing and delivery obligations that would otherwise fall due between March 13, 2020 and April 30, 2020, where the deadline cannot be met “due to circumstances related to current or potential effects of COVID-19.” As a result of the Updated Order, that relief now extends to all Form ADV and Form PF filing obligations originally due on or before June 30, 2020. Therefore, Q1 2020 Form PF filings for private fund managers classified as “large hedge fund advisers” (due on May 30, 2020) are now covered by the relief.
Under the Updated Order, private fund managers are still required to notify the SEC (and in the case of Form ADV filings, also post on their website or notify clients) that they are relying on the Order; however the Updated Order eliminates the requirements in the Original Order to include (i) a brief description of the reasons why the manager could not file on a timely basis and (ii) the date on which the manager estimates that it will make the relevant filing or delivery. A simple statement that the manager is relying upon the Order is all that is required.
Managers seeking to take advantage of this relief should note that:
Private fund managers should also note that, subsequent to the Original Order but prior to the issuance of the Updated Order, the SEC’s Office of Compliance Inspections and Examinations issued a statement confirming that “reliance on regulatory relief will not be a risk factor utilized in determining whether OCIE commences an examination. We encourage registrants to utilize available regulatory relief as needed.”[3] However, managers that elect to utilize this relief should be prepared to explain in any examination that does commence why the manager’s utilization of the relief does not indicate that its business continuity program is deficient.
As with the Original Order, private fund managers should consider the potential benefits and drawbacks of the Updated Order before electing to claim this relief.
Authored by Brian T. Daly and Marc E. Elovitz.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
This Alert replaces an SRZ Alert published on March 15, 2020 titled Form ADV — Coronavirus Update for Private Fund Managers — Limited SEC Form ADV and Form PF Filing Relief.
[1] Available at https://www.sec.gov/rules/other/2020/ia-5469.pdf.
[2] Available at https://www.sec.gov/rules/other/2020/ia-5463.pdf.
[3] OCIE Statement on Operations and Exams – Health, Safety, Investor Protection and Continued Operations are our Priorities, available at https://www.sec.gov/ocie/announcement/ocie-statement-operations-health-safety-investor-protection-and-continued.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.
.

ARTICLE / CLIENT ALERT
March 30, 2020
Read time: 3 min
On March 27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), a $2-trillion stimulus bill, with the most significant impact for small businesses resulting from the allocation of $349 billion for small-business loans. Under the “Paycheck Protection Program” created by the CARES Act, eligible small businesses will have access to government-backed forgivable loans (“Loan(s)”) through an expansion of Section 7(a) of the Small Business Act, which is administered by the Small Business Administration (“SBA”). The Loans are available until June 30, 2020.
This Alert addresses the Loans and changes to other government-supported loans available to small businesses through the SBA, as well as certain employment issues and tax law changes that affect such small businesses. The SBA is expected to issue regulations to govern the implementation of the Paycheck Protection Program. The Secretary of the Treasury will be releasing additional guidance and additional Alerts will be published as regulations or additional guidance is released.
Read full Alert .
For more information on the CARES Act and emerging legal issues on the COVID-19 crisis, visit our COVID-19 Resource Center.
Authored by Stuart D. Freedman, Andrew J. Fadale, Ian L. Levin, David J. Passey, Joseph P. Vitale, David M. Rothenberg, Adam J. Barazani and Travis Gantt.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

ARTICLE / CLIENT ALERT
March 29, 2020
Read time: 5 min
On March 26, 2020, the US Food and Drug Administration issued FAQs on 3D printing of medical devices, accessories, components and parts during the Coronavirus (COVID-19) pandemic. While the use of 3D printers can help address critical device shortages, FDA recommends healthcare professionals take additional precautions when using 3D-printed products that have not undergone FDA premarket review.
As demand for critical medical devices and personal protective equipment (PPE) continues to exceed available supplies, healthcare professionals (HCPs), consumers and companies are evaluating 3D printing options to create the necessary supply. On March 26, 2020, the US Food and Drug Administration (FDA) issued FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic.
FDA regulates devices made with 3D printing technology in the same manner as it regulates devices made using other manufacturing processes. In 2016, FDA issued draft guidance on Technical Considerations for Additive Manufactured Devices to clarify device design, manufacturing and testing considerations for device manufacturers using 3D printing. FDA recommends that entities interested in using 3D printing technology to manufacture devices review this document for best practices and recommendations to address quality and performance issues.
The FAQ also addresses several COVID-19-specific issues of interest, such as:
Key Takeaways: While FDA is willing to permit the use of 3D printing to help address critical device shortages, the agency notes that 3D-printed masks may not provide the same level of protection as FDA-cleared surgical masks and N95 respirators. Therefore, the agency is encouraging HCPs to take additional precautions when using 3D-printed products that have not undergone FDA premarket review. Other entities who wish to make, distribute or sell 3D-printed PPE are encouraged to contact the agency at COVIDManufacturing@fda.hhs.gov.